[
1. Gaddi AV, Galuppo P, Yang J. Creatine Phosphate Administration in Cell Energy Impairment Conditions: A Summary of Past and Present Research. Heart Lung Circ. 2017; 26(10):1026-35.10.1016/j.hlc.2016.12.020
]Search in Google Scholar
[
2. Weiss R, Gerstenblith G, Bottomley P. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005; 102(3):808-13.10.1073/pnas.0408962102
]Search in Google Scholar
[
3. Pascual F, Coleman R. Fuel Availability and Fate in Cardiac Metabolism: A Tale of Two Substrates. Biochim Biophys Acta. 2016; 1861(10):1425-33.10.1016/j.bbalip.2016.03.014
]Search in Google Scholar
[
4. Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012; 15(6):805-12.10.1016/j.cmet.2012.04.006
]Search in Google Scholar
[
5. Lopez R, Marzban B, Gao X, Lauinger E, Van den Bergh F, Whitesall SE, Converso-Baran K, Burant CF, Michele DE, Beard DA. Impaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing Hearts. Function (Oxf). 2020;1(2):zqaa018. doi: 10.1093/function/zqaa018. Epub 2020 Sep 22.
]Open DOISearch in Google Scholar
[
6. Cao F, Zervou S, Lygate C. Тhе creatine kinase system as a therapeutic target for myocardial ischaemia–reperfusion injury. Biochem Soc Trans. 2018; 46(5):1119-27.10.1042/BST20170504
]Search in Google Scholar
[
7. Zhang W, Zhang H, Xing Y. Protective Effects of Phosphocreatine Administered Post-Treatment Combined With Ischemic Post-Conditioning on Rat Hearts With Myocardial Ischemia/Reperfusion Injury. J Clin Med Res. 2015; 7(4):242-7.10.14740/jocmr2087w
]Search in Google Scholar
[
8. Vinten-Johansen J, Shi W. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):260-6.10.1177/1074248411415270
]Search in Google Scholar
[
9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-58.10.1016/0003-2697(79)90738-3
]Search in Google Scholar
[
10. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8.10.1016/0003-2697(82)90118-X
]Search in Google Scholar
[
11. Auclair C, Voisin E (1985). Nitroblue tetrazolium reduction. In: Greenvvald RA (ed) Handbook of methods for oxygen radical research. CRC Press Une, Boca Raton, pp 123-132.
]Search in Google Scholar
[
12. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980; 38(1-2): 161-70.10.1016/0022-1759(80)90340-3
]Search in Google Scholar
[
13. Klabunde, Richard E. Cardiovascular Physiology Concepts. Philadelphia, PA: Lippincott Williams & Wilkins/Wolters Kluwer, 2012.
]Search in Google Scholar
[
14. González-Montero J, Brito R, Gajardo AIJ, Rodrigo R. Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities. World J Cardiol. 2018; 10(9): 74–86.10.4330/wjc.v10.i9.74618906930344955
]Search in Google Scholar
[
15. Kryzhanovskii SA, Kandelaki IN, Sharov VG, Kaverina NV, Sakset VA. Effect of exogenous phosphocreatine on the size of experimental myocardial infarction. Kardiologiia. 1988; 28:88–91.
]Search in Google Scholar
[
16. Prabhakar G, Vona-Davis L, Murray D, Lakhani P, Murray G. Phosphocreatine Restores High-Energy Phosphates in Ischemic Myocardium: Implication for Off-Pump Cardiac Revascularization. J Am Coll Surg. 2003; 197(5):786-91.10.1016/j.jamcollsurg.2003.05.00114585415
]Search in Google Scholar
[
17. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardialinjury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285(2):H579-H588.10.1152/ajpheart.01064.200212860564
]Search in Google Scholar
[
18. Granfeldt А, Lefer D, Vinten-Johansen J. Protective Ischaemia in Patients: Preconditioning and Postconditioning. Cardiovasc Res. 2009; 83(2):234-46.10.1093/cvr/cvp129270172119398470
]Search in Google Scholar
[
19. Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res. 2013; 113(4):464-77.10.1161/CIRCRESAHA.113.300765382425223908333
]Search in Google Scholar
[
20. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362(23):2155-65.10.1056/NEJMoa090861020558366
]Search in Google Scholar
[
21. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008; 88(2):581-609.10.1152/physrev.00024.2007319957118391174
]Search in Google Scholar
[
22. Stephanou A, Brar B, Liao Z, Scarabelli T, Knight RA, Latchman DS. Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury. Cell Death Differ. 2001; 8(4):434-5.10.1038/sj.cdd.440084611550095
]Search in Google Scholar
[
23. Spindler M, Meyer K, Stromer H, Leupold A, Boehm E, Wagner H, et al. (2004) Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis. Am J Physiol Heart Circ Physiol 287: H1039–1045.10.1152/ajpheart.01016.200315105171
]Search in Google Scholar
[
24. Tokarska-Schlattner M, Epand RF, Meiler F, Zandomeneghi G, Neumann D, Widmer HR, et al. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PLoS One. 2012; 7(8):e43178.10.1371/journal.pone.0043178
]Search in Google Scholar
[
25. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA. Myocardial protection at acrossroads: the need for translation into clinical therapy. Circ Res. 2004; 95:125–134.10.1161/01.RES.0000137171.97172.d7
]Search in Google Scholar
[
26. Zuo L, Zhou T, Pannell BK, Ziegler AC, Best TM. Biological and physiological role of reactive oxygen species—The good, the bad and the ugly. Acta Physiol. 2015; 214:329–348.10.1111/apha.12515
]Search in Google Scholar
[
27. Tann AW, Boldogh I, Meiss G, Qian W, van Houten B, Mitra S, et al. Apoptosis induced by persistent singlestrand breaks in mitochondrial genome: Critical role of EXOG (5′-EXO/endonuclease) in their repair. J. Biol. Chem. 2011; 286:31975–31983.
]Search in Google Scholar
[
28. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002; 84:131–141.10.1016/S0300-9084(02)01369-X
]Search in Google Scholar
[
29. Lesnefsky EJ, Chen Q, Tandler B, Hoppel CL. Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies. Annu Rev Pharmacol Toxicol. 2017; 57: 535-565.10.1146/annurev-pharmtox-010715-103335
]Search in Google Scholar
[
30. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res. 2005; 65(1):16-27.10.1016/j.cardiores.2004.08.007
]Search in Google Scholar
[
31. Fernandez J, Perez-Alvarez JA, Fernandez-Lopez JA. Thiobarbituric acid test for monitoring lipid oxidation in meat. Food Chemistry. 1997;59(3):345-353.10.1016/S0308-8146(96)00114-8
]Search in Google Scholar
[
32. Cunha MP, Martín-de-Saavedra MD, Romero A, Egea J, Ludka FK, Tasca CI, et al. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson’s model. ASN Neuro. 2014; 6(6):1759091414554945.10.1177/1759091414554945435760825424428
]Search in Google Scholar
